Costs associated with blood transfusions in Sweden - The societal cost of autologous, allogeneic and perioperative RBC transfusion

Transfusion Medicine

Volumn 15, Issue 4, 2005, Pages 295-306

  Glenngård, Anna H ^a   Persson, U ^a   Soderman C ^b  

^a SWEDISH INSTITUTE FOR HEALTH ECONOMICS   (Sweden)

^b Janssen Cilag   (Sweden)

Author keywords

Allogeneic; Autologous; Blood transfusion; Intraoperative erythrocyte salvage; Societal cost; Sweden

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION REACTION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ERYTHROCYTE TRANSFUSION; HEALTH CARE COST; HOSPITAL PERSONNEL; HUMAN; MEDICAL INFORMATION; PERIOPERATIVE PERIOD; SALVAGE THERAPY; SWEDEN; BLOOD TRANSFUSION; COMPARATIVE STUDY; ECONOMICS;

ANEMIA; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; ERYTHROCYTE TRANSFUSION; HEALTH CARE COSTS; HUMANS; PERIOPERATIVE CARE; SWEDEN;

EID: 27744470702     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.0958-7578.2005.00591.x     Document Type: Article

References (59)

1. Alvarez, M., Oyonarte, S., Rodriguez, P.M. & Hernández, J.M. (2002) Estimated risk of transfusion-transmitted viral infections in Spain. Transfusion, 42, 994-998.
2. Amin, M., Fergusson, D., Aziz, A., Wilson, K., Coyle, D. & Hébert, P. (2003) The cost of allogeneic red blood cells - a systematic review. Transfusion Medicine, 13, 275-285.
3. Berseus, O. & Norda, R. (2003) Swedish National Board of Health and Welfare (Socialstyrelsen), Stockholm.
4. Berseus, O. & Norda, R. (2004) Swedish National Board of Health and Welfare (Socialstyrelsen), Stockholm.
5. Bierbaum, B.E., Callaghan, J.J., Galante, J.O., Rubash, H.E. & Tooms, R.E. (2000) An analysis of blood management in patients having a total hip or knee replacement. The Journal of Bone and Joint Surgery. American Volume, 81, 2-10.
6. Blomqvist, H. & Sondell, K. (2003) Intensivvårdspatienter behöver blodtransfusioner - med måtta. Risk måste avvägas mot nytta på individuell basis. Lakartidningen, 100, 3307-3310.
7. Blumberg, N. (1997) Allogeneic Transfusion and Infection: Economic and Clinical Implications. Seminars in Hematology, 34, 34-40.
8. Blumberg, N., Heal, J.M. & Gettings, K.F. (2003) WBC reduction of RBC transfusion is associated with a decreased incidence of RBC alloimmunization. Transfusion, 43, 945-952.
9. Blumberg, N., Kirkley, S.A. & Heal, J.M. (1996) A Cost Analysis of Autologous and Allogeneic Transfusions in Hip-replacement Surgery. American Journal of Surgery, 171, 324-330.
10. Capraro, L. (2001) Finnish Red Cross Blood Transfusion Service and the Department of anaesthesiology and intensive care medicine. University of Helsinki, Helsinki, Finland.
11. Carson, J.L., Altman, D.G., Duff, A., Noveck, H., Weinstein, M.P., Sonnenberg, F.A., Hudson, J.I. & Provenzano, G. (1999) Risk of bacterial infection associated with allogenic blood transfusion among patients undergoing hip fracture repair. Transfusion, 39, 694-700.
12. Chang, H., Hall, G.A., Geerts, W.H., Greenwood, C., McLeod, R.S. & Sher, G. (2000) Allogenic Red Blood Cell Transfusion is an Independent Risk Factor for the Development of Postoperative Bacterial Infection. Vox Sanguinis, 78, 13-18.
13. Chelemer, S.B., Prato, B.S., Cox, P.M., O'Connor, G.T. & Morton, J.R. (2002) Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. The Annals of Thoracic Surgery, 73, 138-142.
14. Chiavetta, J.A., Escobar, M., Newman, A.M., He, Y., Driezen, P., Deeks, S., Hone, D.E., O'Brien, S.F. & Sher, G. (2003) Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-lymphotropic viruses in blood donors in Canada, 1990-2000. Canadian Medical Association Journal, 169, 767-773.
15. Coyle, D., Lee, K.M., Fergusson, D. & Laupacis, A. (2000) Cost Effectiveness of Epoetin-alpha to Augment Preoperative Autologous Blood Donation in Elective Cardiac Surgery. PharmacoEconomics, 18, 161-171.
16. Dalén, T. & Engström, G. (1996) Blodåtervinning inom ortopedin i Sverige - Sårblodsåtervinning vanligaste metoden. Lakartidningen, 93, 4448-4452.
17. Domen, R.E. & Hoeltge, G.A. (2003) Allergic transfusion reactions - An evaluation of 273 consecutive reactions. Archives of Pathology & Laboratory Medicine, 127, 316-320.
18. Etchason, J., Petz, L., Keeler, E., Calhoun, L., Kleinman, S., Snider, C., Fink, A. & Brook, R. (1995) The cost effectiveness of preoperative blood donations. The New England Journal of Medicine, 332, 719-724.
19. Fernandez, M.C., Gottlieb, M. & Menitove, J.E. (1992) Blood transfusion and postoperative infection in orthopaedic patients. Transfusion, 32, 318-322.
20. Fontaine, M.J., Winters, J.L., Moore, S.B., McGregor, C.G.A. & Santrach, P.J. (2003) Frozen preoperative autologous blood donation for heart transplantation at the Maya Clinic from 1988 to 1999. Transfusion, 43, 476-480.
21. Goodnough, L.T. (2003) Risks of blood transfusion. Critical Care Medicine, 31 (12 Suppl.), 678-686.
22. Goodnough, L.T., Brecher, M.E., Kanter, M.H. & AuBuchon, J.P. (1999) Blood transfusion. First of two parts. Transfusion Medicine, 340, 438-447.
23. Goodnough, L.T. & Despotis, G.J. (2001) Transfusion medicine: support for patients undergoing cardiac surgery. The American Journal of Cardiovascular Drugs, 1, 337-351.
24. Groopman, J.E. & Itri, L.M. (1999) Chemoteraphy-Induced Anaemia in Adults: Incidence and Treatment. Journal of National Cancer Institute, 91, 1616-1634.
25. Hadjianastassiou, V.G., Virich, G. & Lennox, I.A. (2002) Use of blood transfusion service in total knee replacement arthroplasty. The cost implications. Knee, 9, 145-148.
26. Henderson, P.A. & Pinder, L. (1990) Acute transfusion reactions. The New Zealand Medical Journal, 24, 509-511.
27. Hoeltge, G.A., Domen, R.E., Rybicki, L.A. & Schaffer, P.A. (1995) Multiple red cell transfusions and alloimmunisation. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Archives of Pathological Laboratory Medicine, 119, 42-45.
28. Innerhofer, P., Walleczek, C., Luz, G., Hobisch-Hagen, P., Benzer, A., Stöckl, B., Hassenberger, G., Nussbaumer, W. & Schobersberger, W. (1999) Transfusion complications: Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthpedic patients. Transfusion, 93, 625-632.
29. Jensen, L.S., Kissmeyer-Nielsen, P., Wolff, B. & Qvist, N. (1996) Randomised comparison of leukocyte-depleted versus buffy-coat-poor blood transfusions and complications after colorectal surgery. Lancet, 348, 841-845.
30. Kanavos, P.G., Yfantopoulos, J.Y. & Politis, C. (2004) Poster: The Economics of Blood: Evidence from Greece. NATA 5th Annual Symposiumon Transfusion Medicine and Alternatives, Athens, Greece, 18-19 March 2004.
31. Kemper, R.R., Menitove, J.E. & Hanto, D.W. (1997) Cost analysis of intraoperative bloodsalvage during orthopaedic liver transplantation. Liver Transplantation and Surgery, 5, 513-517.
32. Kreuger, A. & Åkerblom, O. (2002) Transfusioner av blodkomponenter till barn - Aktuella rekommendationer. Läkartidningen, 99, 502-506.
33. Kuehnert, M.J., Roth, V.R., Haley, N.R., Gregory, K.R., Elder, K.V., Schreiber, G.B., Arduino, M.J., Holt, S.C., Carson, L.A., Banerjee, S.N. & Jarvis, W.R. (2001) Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion, 41, 1493-1499.
34. Lee, S.J., Neumann, P.J., Churchill, W.H., Cannon, M.E., Weinstein, M.C. & Johannesson, M. (1997) Patients willingness to pay for autologous blood donation. Health Policy, 40, 1-12.
35. Lindgren, B. (1981) In: Lund Economic Studies, Lund University, Lund.
36. Mollison, P.L., Engelfreit, C.P. & Contreras, M. (1993) Blood Transfusion in Clinical Medicine. Blackwell scientific publications, Oxford.
37. Murphy, P. & Blumberg, N. (1991) Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion, 31, 212-217.
38. National Board of Health and Welfare (1995) Autolog transfusion SOS-Report 1995: 7 (Autologous transfusion). Swedish National Board of Health and Welfare (Socialstyrelsen).
39. National Board of Health and Welfare (2001) SOSFS 2001: 2. Swedish National Board of Health and Welfare (Socialstyrelsen).
40. Pillonel, J., Laperche, S., Saura, C., Desenclos, J.C. & Couroucé, A.M. (2002) Trends in residual risk of transfusion-transmitted viral infection in France between 1992 and 2000. Transfusion, 42, 980-988.
41. Roberts, W.A., Kirkley, S.A. & Newby, M. (1996) A cost comparison of allogeneic and preoperative or intraoperatively donated autologous blood. Anaesthesia and Analgesia, 83, 129-133.
42. Sauaia, A., Alexander, W., Moore, E.E., Stevens, B.R., Rosen, H. & Dunn, T. (1999) Autologous Blood Transfusions Does Not Reduce Postoperative Infection Rates in Elective Surgery. American Journal of Surgery, 178, 549-555.
43. Saverimuttu, J., Greenfield, T., Rotenko, I., Crozier, J., Jalaludin, B. & Harvey, M. (2003) Implications for urgent transfusion of uncrossmatched blood in the emergency department: the prevalence of clinically significant red cell antibodies within different patient groups. Emergency Medicine Journal, 15, 243-293.
44. Sazama, K. (1990) Report of 355 transfusion-associated deaths: 1976 through 1985. Transfusion, 30, 583-590.
45. Shanwell, A. (2000) Blodtransfusion aldrig helt biverkningsfri - Filtrerade erytrocytkoncentrat bör användas. Lakartidningen, 97, 1782-1787.
46. Slappendal, R., Dirksen, R., Weber, E. & van den Schaaf, D. (2003) An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery. Acta Orthopaedica Scandinavica, 74, 569-575.
47. Sonnenberg, F.A., Yomtovian, G.R., Russel, L.B., Tierney, W., Kosmin, M. & Carson, J.L. (1999) The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion. Transfusion, 39, 808-817.
48. Southern Regional Health Care Board (2003) Southern regional health care board.
49. Statistics Sweden (2001) Stockholm.
50. Swedish Federation of County Councils (2004) Swedish Federation of County Councils (Landstingsförbundet).
51. Theakston, E.P., Morris, A.J., Streat, S.J., Baker, B.W. & Woodfield, D.G. (1997) Transfusion transmitted Yersina enterocolita infection in New Zealand. Australian and New Zealand Journal of Medicine, 27, 62-67.
52. Tretiak, R., Laupacis, A., Riviere, M., McKerracher, K. & Souetre, E. (1996) Cost of allogeneic and autologous blood transfusions in Canada. Canadian Medical Association Journal, 154, 1501-1508.
53. Triulzi, D.J., Vanek, K., Ryan, D.H. & Blumberg, N. (1992) A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion, 32, 517-524.
54. Tynell, E., Norda, R., Shanwell, A. & Björkman, A. (2001) Long-term survival in transfusion recipients in Sweden, 1993. Transfusion Practice, 41, 251-255.
55. Vamvakas, E.C., Carven, J.H. & Hibberd, P.L. (1996) Blood transfusion and infection after colorectal surgery. Transfusion, 36, 1000-1008.
56. Varney, S.J. & Guest, J.F. (2003) The annual cost of blood transfusions in the UK. Transfusion Medicine, 13, 205-218.
57. Velati, C., Romanò, L., Baruffi, L., Pappalettera, M., Carreri, V. & Zanetti, A. R. (2002) Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy. Transfusion, 42, 989-993.
58. Wagner, S.J. (2004) Transfusion-transmitted bacterial infections: risk, sources and interventions. Vox Sanguinis, 86, 157-163.
59. Webert, K.E. & Blajchman, M.A. (2003) Transfusion-Related Acute Lung Injury. Transfusion Medicine Reviews, 17, 252-262.